AzTrials
AzTrials

Nonsuicidal Self InjuryNCT05325944

Digital Mental Health Intervention for Nonsuicidal Self-Injury in Young Adults

A study testing Self-guided digital intervention for NSSI and Digital intervention for NSSI with coaching in people with Nonsuicidal Self Injury and Suicidal Ideation, run by Northwestern University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is a feasibility trial of a digital mental health intervention aimed at young adults (ages 18-25) with nonsuicidal self-injury and who are not currently engaged in mental health treatment. Read more about this study

Who is it for?
Ages 18 to 24 years
What is being tested?
Self-guided digital intervention for NSSI and Digital intervention for NSSI with coaching
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteUnited States
Study dates
2 Aug 2024to 18 Aug 2025
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 24 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Ages 18-24 *The age to provide consent in Nebraska is 19. Individuals recruited from the state of Nebraska must be 19 or older.
  • Current NSSI, defined as self-injury on 2 or more days in the past month
  • Has a smartphone
  • English language skills sufficient to engage in the consent and intervention procedures

Who cannot join

  • Serious mental illness for which intervention would be contraindicated (e.g., psychotic disorder, manic episode, etc.)
  • Severe suicidality (i.e., experiencing suicidal ideation with a plan and intent to act)
  • Current engagement in psychotherapy

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Northwestern University

    Chicago, Illinois, 60611

Other trials in United States

About this study

This is a feasibility trial of a digital mental health intervention aimed at young adults (ages 18-25) with nonsuicidal self-injury and who are not currently engaged in mental health treatment. We will pilot three arms: a self-guided DMHI, the DMHI with low-intensity coaching, or an active control which will involve the delivery of non-interactive psychoeducational content via the same app interface. The primary goals of this project are to evaluate the feasibility of the intervention and trial procedures in preparation for a fully-powered randomized-controlled trial.

Read the detailed description

The primary purpose of this trial is to test the feasibility of conducting a randomized controlled trial (RCT) of an 8-week digital mental health intervention (DMHI) for non-treatment engaged young adults with repeated nonsuicidal self-injury. The DMHI will be a highly interactive conversational agent that conveys psychoeducational content and guides participants through skill-based activities. We will conduct a 3-arm feasibility trial, randomizing participants to receive the self-guided DMHI, the DMHI with low-intensity coaching, or an active control which will involve the delivery of non-interactive psychoeducational content via the same app interface. Initial randomization will be generated in permuted blocks of 6 using a computer program, with participants assigned on a 1:1:1 ratio. To prevent allocation bias, randomization will be conducted by the biostatistician, who will not inform the study team of the treatment arms until the baseline assessment has been completed and the patient has been enrolled. The control group will serve as the reference group to verify the effectiveness of the DMHI while the comparison of self-guided to coached deployments will evaluate the added benefit of coaching.

The primary clinical outcome measures will be frequency of NSSI behavior (ABASI) and frequency of NSSI urges (ABUSI). Secondary outcomes will include suicidal ideation (DSI-SS), depressive symptom severity (PHQ-9), and anxiety symptom severity (GAD-7).

This study will enroll individuals who have meet the following eligibility criteria: 1) current NSSI, defined as 2+ self-injury episodes (e.g., cutting, burning) in the past month; 2) Age 18 to 24; 3) English language skills sufficient to engage in the consent and intervention procedures. Participants will be excluded if they 1) Have a severe mental illness diagnosis (e.g., psychotic disorder); 2) Are imminently suicidal, with a plan and intent; or 3) Are currently receiving psychotherapy.

Coaching will consist of providing users with support and accountability via positive reinforcement, goal and expectation setting, and monitoring. Coaching outreach will focus on adherence to the treatment but will not provide treatment advice. Coaches will provide a brief (20-30 minute phone call or equivalent depending on the medium) engagement phone call. Thereafter, coaches will check in with participants via messaging, phone call, or email, twice per week and respond to patient messages.

Being tested
Self-guided digital intervention for NSSI, Digital intervention for NSSI with coaching, Active control
Keywords
Digital Mental Health, Nonsuicidal Self Injury, mHealth, Mobile phone, Smartphone, Coach, Conversational Agent
Medical subject headings
Self-Injurious Behavior, Suicidal Ideation, Depression, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Self-guided digital intervention for NSSIBehavioural

    Psychoeducational content, skill-based practice, and daily ecological momentary assessments will be delivered over an 8-week period.

    Psychological strategies center on cognitive behavioral principles and acceptance-based emotional regulation strategies. Daily EMAs assess NSSI and use of cognitive, behavioral, and emotion regulatory strategies.

  • Digital intervention for NSSI with coachingBehavioural

    Psychoeducational content and psychological strategies center on cognitive behavioral principles and acceptance-based emotional regulation strategies. Daily EMAs assess NSSI and use of cognitive, behavioral, and emotion regulatory strategies. Human coaching will be used to support intervention use and engagement twice per week via text, call or email.

  • Active controlBehavioural

    Psychoeducational content and psychological strategies center on cognitive behavioral principles and acceptance-based emotional regulation strategies.

Study groups in NCT05325944
Study groupRoleWhat they receive
Self-guided digital intervention for NSSIExperimentalThe self-guided digital intervention for NSSI will consist of 8 weekly modules containing psychoeducation and skill-based practice, and daily ecological momentary assessments. All content is delivered by a highly interactive conversational agent that guides users through the app content via a text-like interface.
Receives: Behavioral: Self-guided digital intervention for NSSI
Digital intervention for NSSI with coachingExperimentalThe self-guided digital intervention for NSSI will consist of 8 weekly modules containing psychoeducation and skill-based practice, and daily ecological momentary assessments. All content is delivered by a highly interactive conversational agent that guides users through the app content via a text-like interface. This arm will additionally receive lightweight coaching which consists of a one 20-30 minute engagement call at the beginning of treatment. Thereafter, coaches will check in with participants via medium of participants choice twice per week and respond to patient texts, calls, or emails.
Receives: Behavioral: Digital intervention for NSSI with coaching
Active controlActive comparatorThe active control arm will receive 8 weekly modules with psychoeducational components only, without the interaction features or EMA for personalization.
Receives: Behavioral: Active control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Alexian Brothers Assessment of Self-Injury - Methods Checklist

    16-item checklist that assesses the frequency (days/times) of common NSSI methods within the past month. Higher scores indicate engagement in NSSI on more days. Minimum: 0 days; Maximum: 31 days

    Measured: 16 weeks

  2. Alexian Brothers Urges to Self-Injure Scale

    5-item self-report measure assessing the frequency of urges to self-injure, intensity of urges, time spent thinking about self-injury, ability to resist urges and thoughts associated with self-injury urges. Each item is scored on a 7-point Likert scale from 1 to 7. Scores are summed to produce a total score ranging from 5 to 35. Score is averaged across items here. Higher scores indicate stronger urges to self-injure.

    Measured: 16 weeks

Secondary outcomes (4)
  1. Patient Health Questionnaire-9

    10-item self-report measure assessing depression symptom severity over the past two weeks. Higher scores mean greater symptom severity. Minimum score: 0; maximum score: 27.

    Measured: 16 weeks

  2. Generalized Anxiety Disorder-7

    7-item self-report measure assessing generalized anxiety disorder symptom severity. Higher scores mean greater symptom severity. Minimum score: 0; maximum score: 21.

    Measured: 16 weeks

  3. Borderline Evaluation of Severity Over Time

    15-item, self-report measure of the severity of and changes in borderline personality disorder (BPD) symptoms. The BEST has 3 subscales: A (Thoughts and Feelings); B (Behaviors-Negative), and C (Behaviors-Positive). All items are scored on a 1-5 rating scale, where higher numbers show greater distress or higher frequency of actions. Subscale C is reverse scored. Total score is calculated as the sum of subscale A + sum of subscale B - sum of subscale C + 15 (correction). Total scores range from 12 (best) to 72 (worst); higher scores are associated with higher levels of BPD symptoms.

    Measured: 16 weeks

  4. Depression Symptom Inventory - Suicidality Subscale

    4-item self-report questionnaire assessing the frequency and intensity of suicidal thoughts over previous two weeks. Higher scores signal greater frequency and severity of suicidal thoughts. Minimum score: 0; maximum score: 12.

    Measured: 16 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Apr 2022
  2. Study start2 Aug 2024
  3. Primary completion18 Aug 2025
  4. Study completion18 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05325944
Sponsor's protocol ID
R34MH128410
Status last verified
Apr 2025
First submitted
4 Apr 2022
Last updated
29 Oct 2026
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified data will be shared through and managed by the NIMH Data Archive (NDA). De-identified human subjects data, harmonized to a common standard, are available to qualified researchers.

Questions about this trial

What is this clinical trial studying?

A study testing Self-guided digital intervention for NSSI and Digital intervention for NSSI with coaching in people with Nonsuicidal Self Injury and Suicidal Ideation, run by Northwestern University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 29 Oct 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Alexian Brothers Assessment of Self-Injury - Methods Checklist (time frame: 16 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in